News

G protein-coupled receptor, class C, group 5, member D (GPRC5D) loss after chimeric antigen receptor (CAR) T-cell therapy in ...
One of the few drug trials for a possible long Covid ended in disappointment. But lessons are leading to a second chance.
Superluminal Medicines, a drug discovery company integrating AI/ML, protein dynamics, and structural biology to rapidly unlock the most challenging G protein-coupled receptors (GPCRs), today announced ...
Funding will be specifically used to accelerate the clinical development of urcosimod (formerly called OK-101).
Classical psychedelics like LSD, psilocybin, and mescaline are known for activating the 5-HT2A serotonin receptor, but a new ...
According to the latest study from BCC Research, "Global Fuel Cell Generator Market" is projected to increase from $1.4 ...
Amino acids play a fundamental role in regulating how cells respond to drugs. These molecules, which form proteins, act like ...
According to the latest study from BCC Research, "Nonwoven Filter Media: Global Markets" is expected to grow from $6.6 ...
This non-dilutive capital strengthens OKYO Pharma’s ability to execute on its development strategy without impacting existing shareholder equity. The funds will be used to advance key clinical ...
The global Biosimilars Market , valued at US$32.75 billion in 2024 stood at US$35.04 billion in 2025 and is projected to ...
Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets" is expected to grow from $4.4 billion in 2024 to $6.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of ...
Patients with a mysterious eye pain disease may be one step closer to seeing the first approved treatment for their condition ...